We recently demonstrated the upregulation of EMT and motility biomarkers in the cancer cells of vessel co-opting CRCLM lesions, which correlated with the upregulation of transforming growth factor beta 1 (TGFβ1) in their proximate liver parenchyma [32]. This evidence concerns the gene TGFB1 and cancer.